Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Am J Kidney Dis. 2021 Feb 27;78(4):530–540.e1. doi: 10.1053/j.ajkd.2021.01.009

Table 4:

Cross-sectional Association between Urine Biomarkers of Kidney Tubule Injury and Dysfunction and Measures of Cognitive Function in 2253 SPRINT Participants with CKD

Biomarker Digit Symbol Coding (range 0–135) Logical Memory Test 1 (Immediate Recall) (range 0–28) 2 (Delayed Recall) (range 0–14)
B coefficient (95% CI)
Log 2 IL-18, pg/mL
 Unadjusted −0.58 (−1.09, −0.07)* −0.12 (−0.29, 0.06) −0.04 (−0.16, 0.08)
 Adjust0EDA −0.001 (−0.60, 0.59) −0.07 (−0.31, 0.16) −0.01 (−0.17, 0.15)
 Adjusted + eGFR & albuminb 0.04 (−0.59, 0.67) −0.10 (−0.35, 0.15) −0.01 (−0.18, 0.16)
Log 2 NGAL, ng/mL
 Unadjusted −0.74 (−1.12, −0.37)*** −0.10 (−0.23, 0.03) −0.03 (−0.12, 0.06)
 Adjusteda −0.53 (−0.98, −0.07) −0.11 (−0.28, 0.07) −0.04 (−0.16, 0.08)
 Adjusted + eGFR & albumin −0.49 (−0.96, −0.02)* −0.11 (−0.29, 0.07) −0.04 (−0.16, 0.09)
Log 2 YKL-40, pg/mL
 Unadjusted −0.60 (−0.89, −0.30)*** −0.07 (−0.18, 0.03) −0.02 (−0.09, 0.05)
 Adjusteda −0.24 (−0.60, 0.11) −0.01 (−0.15, 0.13) −0.03 (−0.12, 0.07)
 Adjusted + eGFR & albumin −0.27 (−0.63, 0.10) −0.02 (−0.17, 0.12) −0.03 (−0.13, 0.07)
Log 2 KIM-1, pg/mL
 Unadjusted −0.27 (−0.69, 0.15) −0.06 (−0.21, 0.08) −0.11 (−0.21, 0.01)
 Adjusteda −0.47 (−0.96, 0.02) 0.02 (−0.17, 0.21) −0.11 (−0.23, 0.03)
 Adjusted + eGFR & albuminb −0.41 (−0.92, 0.11) 0.03 (−0.17, 0.23) −0.10 (−0.24, 0.03)
Log 2 MCP-1, pg/mL
 Unadjusted −1.12 (−1.61, −0.63)*** −0.32 (−0.49, −0.15)*** −0.27 (−0.38, −0.15)***
 Adjusteda −0.56 (−1.13, 0.002) −0.15 (−0.37, 0.08) −0.15 (−0.30, 0.003)
 Adjusted + eGFR & albuminb −0.55 (−1.14, 0.03) −0.16 (−0.39, 0.07) −0.15 (−0.31, 0.004)
Log 2 α1M, mg/g
 Unadjusted −0.91 (−1.43, −0.39)** −0.37 (−0.55, −0.19)*** −0.31 (−0.43, −0.19)***
 Adjusteda −0.19 (−0.78, 0.41) −0.12 (−0.35, 0.11) −0.07 (−0.23, 0.08)
 Adjusted + eGFR & albuminb 0.09 (−0.60, 0.77) −0.12 (−0.39, 0.15) −0.07 (−0.25, 0.12)
Log 2 β2M, ng/mL
 Unadjusted −0.43 (−0.67, −0.20)*** −0.11 (−0.20, −0.03)** −0.10 (−0.16, −0.04)***
 Adjusteda −0.33 (−0.59, −0.07)* −0.02 (−0.12, 0.08) −0.04 (−0.11, 0.03)
 Adjusted + eGFR & albuminb −0.29 (−0.56, −0.02)* −0.01 (−0.12, 0.10) −0.03 (−0.11, 0.04)
Log 2 Umod, ng/mL
 Unadjusted 1.05 (−0.39, 1.71)** −0.10 (−0.33, 0.13) −0.14 (−0.30, 0.02)
 Adjusteda 0.04 (−0.73, 0.80) −0.21 (−0.51, 0.09) −0.30 (−0.50, −0.10)**
 Adjusted + eGFR & albuminb −0.25 (−1.07, 0.56) −0.30 (−0.62, 0.01) −0.37 (−0.58, −0.15)**
Log 2 albumin, mg/L
 Unadjusted −0.66 (−0.95, −0.36)*** −0.17 (−0.28, −0.07)** −0.14 (−0.21, −0.07)***
 Adjusteda −0.18 (−0.52, 0.15) −0.01 (−0.14, 0.12) −0.02 (−0.11, 0.07)
 Adjusted + eGFR & albuminb −0.07 (−0.43, 0.28) 0.02 (−0.12, 0.16) −0.01 (−0.10, 0.09)

Note. MoCA, Montreal Cognitive Assessment; IL-18, interleukin-18; KIM-1, kidney injury molecule-1; NGAL, neutrophil gelatinase-associated lipocalin; MCP, monocyte chemoattractant protein-1; β2M, β2-microglobulin; A1M, α1-microglobulin; UMOD, uromodulin.

a

Adjusted for age, race, sex, body mass index, alcohol use, years of education, insurance status, baseline systolic and diastolic blood pressure, smoking status, and urine creatinine

B

Adjusted for all variables listed above and estimated glomerular filtration rate (eGFR) and Log2 albumin.

*

P<0.05;

**

P<0.01;

***

P<0.001